Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia

被引：0
|
作者：
Serrano, Josefina
Buenasmananas, Diana
Herrera, P.
Amigo, Mari Luz
Calabuig, Marisa
Martin, Eusebio
Vidriales, Maria Belen
de la Fuente, Adolfo
Santero, M.
Negri, Silvia
Gonzalez-Campos, Jose
Albo, Carmen
Gonzalez, Sonia
Rifon, Jose J.
Viguria, M. Cruz
Garcia-Gutierrez, V.
Martin, Carmen
Sanchez-Garcia, Joaquin
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3410.3410
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3410
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML - Interim Results of the Bridge Trial
    Middeke, Jan Moritz
    Parmentier, Stefani
    Alakel, Nael
    Schaich, Markus
    Thiede, Christian
    Platzbecker, Uwe
    Roellig, Christoph
    Haenel, Mathias
    Stuhler, Gernot
    Morgner, Anke
    Eulenstein, Uta
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    [J]. BLOOD, 2012, 120 (21)
  • [2] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    J M Middeke
    R Herbst
    S Parmentier
    G Bug
    M Hänel
    G Stuhler
    K Schäfer-Eckart
    W Rösler
    S Klein
    W Bethge
    U Bitz
    B Büttner
    H Knoth
    N Alakel
    M Schaich
    A Morgner
    M Kramer
    K Sockel
    M von Bonin
    F Stölzel
    U Platzbecker
    C Röllig
    C Thiede
    G Ehninger
    M Bornhäuser
    J Schetelig
    [J]. Leukemia, 2016, 30 : 261 - 267
  • [3] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    Middeke, J. M.
    Herbst, R.
    Parmentier, S.
    Bug, G.
    Haenel, M.
    Stuhlers, G.
    Schaefer-Eckart, K.
    Roester, W.
    Klein, S.
    Bethge, W.
    Bitz, U.
    Buettner, B.
    Knoth, H.
    Alakel, N.
    Schaich, M.
    Morgner, A.
    Kramer, M.
    Sockel, K.
    von Bonin, M.
    Stoelzel, F.
    Platzbecker, U.
    Roellig, C.
    Thiede, C.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    [J]. LEUKEMIA, 2016, 30 (02) : 261 - 267
  • [4] Clofarabine Salvage Therapy Prior To Allogeneic He atopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML - Results Of The Bridge Trial
    Middeke, Jan Moritz
    Herbst, Regina
    Parmentier, Stefani
    Bug, Gesine
    Haenel, Mathias
    Stuhler, Gernot
    Schaefer-Eckart, Kerstin
    Roesler, Wolf
    Klein, Stefan A.
    Bethge, Wolfgang A.
    Bitz, Ulrich
    Alakel, Nael
    Schaich, Markus
    Morgner, Anke
    Pursche, Stefan
    Kramer, Michael
    Platzbecker, Uwe
    Roellig, Christoph
    Thiede, Christian
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    [J]. BLOOD, 2013, 122 (21)
  • [5] Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
    Elias, Shlomo
    Walji, Moneeza
    Brown, Samantha
    Devlin, Sean M.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Ponce, Doris M.
    Young, James W.
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Shaffer, Brian C.
    Dahi, Parastoo B.
    Lin, Richard J.
    Cho, Christina
    Tamari, Roni
    Smith, Melody
    Gyurkocza, Boglarka
    [J]. BLOOD, 2022, 140 : 10627 - 10628
  • [6] Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Salhotra, Amandeep
    Yang, Dongyun
    Mokhtari, Sally
    Al Malki, Monzr M.
    Ali, Haris
    Sandhu, Karamjeet S.
    Aribi, Ahmed
    Khaled, Samer
    Mei, Matthew
    Budde, Elizabeth
    Snyder, David
    Cao, Thai
    Spielberger, Ricardo
    Marcucci, Guido
    Pullarkat, Vinod
    Forman, Stephen J.
    Nakamura, Ryotaro
    Stein, Anthony
    Aldoss, Ibrahim
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (06) : 1084 - 1090
  • [7] Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia
    Farag, Sherif
    Wood, Lisa L.
    Schwartz, Jennifer E.
    Srivastava, Shivani
    Nelson, Robert P., Jr.
    Robertson, Michael
    Abonour, Rafat
    Sayar, Hamid
    Cripe, Larry D.
    [J]. BLOOD, 2009, 114 (22) : 86 - 86
  • [8] Clofarabine/Cyclophosphamide (ClofCy) for Debulking refractory Acute Leukemias Prior to Allogeneic Hematopoietic Stem Cell Transplantation
    Rabitsch, Werner
    Boehm, Alexandra
    Schellongowski, Peter
    Kalhs, Peter
    Valent, Peter
    Sperr, Wolfgang R.
    [J]. BLOOD, 2012, 120 (21)
  • [9] Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Refractory/Relapsed Acute Leukemia
    Wang, Yu
    Liu, Dai-hong
    Liu, Kai-yan
    Xu, Lan-ping
    Zhang, Xiao-hui
    Han, Wei
    Chen, Huan
    Chen, Yu-hong
    Wang, Feng-rong
    Wang, Jing-zhi
    Fu, Hai-xia
    Huang, Xiao-jun
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S311 - S312
  • [10] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    [J]. CLINICAL TRANSPLANTATION, 2021, 35 (03)
12345